Potential Benefits of Nrf2/Keap1 Targeting in Pancreatic Islet Cell Transplantation
Permanent pancreatic islet cell destruction occurs in type 1 diabetes mellitus (T1DM) through the infiltration of inflammatory cells and cytokines. Loss of β-cell integrity secondary to oxidation leads to an inability to appropriately synthesize and secrete insulin. Allogenic islet cell transplantat...
Saved in:
Main Authors: | Alberto Jarrin Lopez (Author), Hien Lau (Author), Shiri Li (Author), Hirohito Ichii (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Oxidative Therapy in Islet Cell Transplantation
by: Natsuki Eguchi, et al.
Published: (2022) -
KEAP1/NRF2 as a druggable target
by: Dinkova-Kostova Albena T.
Published: (2023) -
Nanowarming of vitrified pancreatic islets as a cryopreservation technology for transplantation
by: Taisei Wakabayashi, et al.
Published: (2023) -
Bilirubin Protects Transplanted Islets by Targeting Ferroptosis
by: Qing Yao, et al.
Published: (2020) -
Dimethyl Fumarate Alleviates Dextran Sulfate Sodium-Induced Colitis, through the Activation of Nrf2-Mediated Antioxidant and Anti-inflammatory Pathways
by: Shiri Li, et al.
Published: (2020)